Airway and Lung Infection
An Introduction to Airway and Lung Infection
The field of airway and lung infection is topical in the wake of the COVID-19 pandemic; SARS-CoV-2 is one of several novel respiratory viruses to emerge in the 21st century. Viruses and bacteria can cause a range of respiratory diseases, including acute bronchitis, the common cold, influenza, respiratory distress syndromes, pertussis, pneumonia and tuberculosis. Symptoms of viral infections may range from being very mild to a severe respiratory illness, and therefore prompt and reliable diagnosis is essential. Antibiotic resistance remains the major challenge in bacterial infection. Emerging approaches include cell-based therapies involving mesenchymal stem cells in the treatment of respiratory infections. However, the multiple challenges involved in developing curative therapies for infections highlight the importance of prevention, and vaccine research is essential.
Browse our selection of video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and a selection of peer-reviewed articles from the journal portfolio.
Airway and Lung Infection Content
8th International Workshop on Lung Health—FUHeL Mentoring Programme
The Future Leaders Mentoring Programme has become one of the most important activities at the annual International Workshop on Lung Health (IWHL) meeting. In this video, we look back at testimonials from previous participants, as the IWHL launches its 2021 edition entitled: The FUHeL (Future Health Leader of Lungs) Mentoring Programme. Further information about this […]
Updates on nontuberculous mycobacteria
Watch leading experts discuss the need for greater awareness and understanding of NTM-LD and a multidisciplinary approach to it’s managment may help improve outcomes for patients
- Recognise the low level of disease awareness and how this can extend the time to a definitive diagnosis of nontuberculous mycobacteria (NTM) lung disease
- Describe the significant burden of NTM for patients, in terms of increased mortality and morbidity and reduced quality of life
- Recall how NTM influences declining lung function over time and the importance of a multidisciplinary approach to NTM management to optimise outcomes
8th International Workshop on Lung Health – Prof. Francesco Blasi
Professor Francesco Blasi, President of the 8th International Workshop on Lung Health, discusses the theme of the next Lung Health Congress, treatable and targetable traits in the management of respiratory disorders. The 8th International Workshop on Lung Health will be held in The Hague, Netherlands 14-16 January 2021. This video was produced by the International […]
Lessons from the Outbreak of E-cigarette-associated Lipoid Pneumonia in North Carolina
US Respiratory & Pulmonary Diseases. 2019;4(1):8–9
Q. What was previously known about the risks of e-cigarette use? E-cigarettes gained rapid popularity in the US after initial release in 2007. Although they were initially marketed towards smokers as a cessation aid, their use became swiftly prevalent with younger audiences including teenagers and young adults who had never previously smoked. In that timeline, […]
Delayed Diagnosis of Kartagener Syndrome in a Fertile Young Man – An Unusual Case
European Respiratory & Pulmonary Diseases. 2019;5(1):25–7.
Primary ciliary dyskinesia (PCD) is an autosomal recessive disease characterised by dysfunction of ciliary motility associated with impaired mucociliary clearance.1 Kartagener syndrome is characterised by the triad of: sinusitis, bronchiectasis and situs inversus.2,3 Situs inversus is a condition whereby the visceral organs are completely, or partially, arranged in a mirror-image reversal of their normal positions.7 […]
Arschang Valipour, ERS 2019 – Bronchial Rheoplasty For Treatment of Chronic Bronchitis
Arschang Valipour, Vienna, Austria, met with us at ERS 2019 in Madrid to discuss the 6-month results from a prospective multi-center study of bronchial rheoplasty for the treatment of chronic bronchitis. Questions 1. What are the most important unmet needs in the treatment of patients with chronic bronchitis? (0:05) 2. Could you tell us a […]
Akio Niimi, ERS 2019 – Novel P2X3 Receptor Antagonist S-600918 in Chronic Cough
Akio Niimi, of Nagoya City University, Japan, spoke to us at ERS 2019 in Madrid about a study of a novel P2X3 receptor antagonist S-600918 in patients with refractory chronic cough. Questions 1. What are the most common causes of chronic cough? (0:05) 2. What is the mechanism of action of S-600918? (0:34) 3. Could […]
Disseminated Nocardiosis Masquerading as an Obstructive Endobronchial Mass—A Case Report
US Respiratory & Pulmonary Diseases. 2019;4(1):20–3
Highlights Nocardiosis is has been coined “the great imitator” due to the vast heterogeneity in clinical presentation. Prevalence of disease is on the rise due to improved diagnostic techniques, as well as a growing population of immunocompromised patients, although up to one-third of patients diagnosed are immunocompetent. There are six forms of disease caused […]
Immunomodulation Therapy – Clinical Relevance of Bacterial Lysates OM-85
European Respiratory & Pulmonary Diseases. 2019;15(1):17–23.
Acute respiratory tract infections (RTIs) affect children and adults with chronic respiratory conditions throughout the world, and are associated with significant morbidity and mortality.1 Acute RTIs are one of the leading causes of mortality in both children and adults, with an estimated 3.5–4 million deaths per year attributed to both acute upper and lower RTIs.2,3 […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!